IVD Antibody Development Services for CK-MB Marker

1. IVD Antibody Development Services for CK-MB Marker Creative Biolabs is one of the well-recognized experts who are professional in applying advanced platforms and technologies for a broad range of in vitrodiagnostics (IVD) antibody discovery against varies of disease markers. Based on our extensive experience and proficient skills, now Creative Biolabs is able to produce the IVD antibodies against Creatine Kinase-MB (CK-MB) for our customers all over the world. Creatine Kinase (CK) is one kind of enzyme which can be expressed in varies cell types and tissues. In the cells, there are two subunits of CK enzymes which are B (brain type) and M (muscle type). Therefore, there are three different types of isoenzymes which are CK-MM, CK-BB, and CK-MB. CK-MB is the form of the enzyme CK which can be found mostly in the heart, but small amounts can be found in skeletal muscles. When there is muscle damage, CK can be released from muscle cells and be detected in the blood. In general, the CK- MB can be present when the damage is in the heart. Currently, CK-MB is the enzyme used as the definitive serum marker for the diagnosis or exclusion of acute myocardial infarction (AMI). CK-MB Marker of Acute Myocardial Infarction AMI refers to the local myocardium ischemic necrosis caused by blood flow interruption and acute coronary artery occlusion. In AMI, the CK-MB level in plasma always rises four to six hours after the chest pains and get to the peak within 12 to 24 hours. Finally, the value can return to the basic level within 24 to 48 hours. The specificity for cardiac tissue makes CK-MB to be a powerful diagnostic tool for the diagnosis of AMI. IVD Antibodies of CK-MB Marker With the rapid development of IVD, IVD antibodies play more and more important roles in the diagnosis of varies of biomarkers. Among the cardiac enzymes, CK-MB is the biomarker for the myocardial damage and has become the most important serum enzyme test in the diagnosis of AMI. Creative Biolabs

2. now can offer the high-affinity IVD antibody discovery and development against CK-MB. Fig.1 Schematic diagram of a SERS-based competitive immunoassay for simultaneous quantification of cTnI and CK-MB markers. (Chon, H., 2014) As a pioneer and the undisrupted global leader in the field of in vitro diagnostics, Creative Biolabs proudly introduces our professional service of IVD antibody discovery against different biomarkers. In terms of years of experience, we would try our best to provide a tailor-designed proposal to meet your specific requirements in the quality, timeline, and budget. If you are interested in our service, please do not hesitate to contact us for more details. Reference 1. Chon, H. (2014). “SERS-based competitive immunoassay of troponin I and CK- MB markers for early diagnosis of acute myocardial infarction.”Chemical Communications, 50(9), 1058-1060. Related Services: IVD Antibodies for miR-1 Marker IVD Antibodies for miR-133a Marker IVD Antibodies for Cholesterol Marker IVD Antibodies for Phenylalanine Marker IVD Antibody Development Services for PCT Marker IVD Antibody Development Services for ApoA, B, E Markers IVD Antibody Development Services for NSE Marker

3. IVD Antibody Development Services for S-adenosylhomocysteine (SAH) Marker IVD Antibody Development Services for Galectin-3 Marker IVD Antibody Development Services for Cystatin C Marker IVD Antibody Development Services for D-dimer Marker IVD Antibody Development Services for Fibrinogen Marker IVD Antibody Development Services for EGF Marker IVD Antibody Development Services for CD54 Marker IVD Antibody Development Services for Lp-PLA2 Marker